Mr. Trump said at a White House meeting with airline executives that he would make an announcement that would be “phenomenal in terms of tax” within the next three weeks.
As has been discussed ad nauseam, a lower US corporate tax rate would greatly benefit small US biotech companies, who don’t have the wherewithal to cut their taxes by shuffling money between multinational subsidiaries. Even if these companies have no taxable income now, the prospect of future (after-tax) profits is what drives their valuations.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.